Levkova Mariya, Hachmeriyan Mari, Grudkova Margarita, Tsalta-Mladenov Mihael, Kaprelyan Ara
Department of Medical Genetics, Medical University Varna, Marin Drinov Str. 55, 9000 Varna, Bulgaria.
Laboratory of Medical Genetics, St. Marina Hospital, Hristo Smirnenski Blv 1, 9000 Varna, Bulgaria.
Reports (MDPI). 2025 May 22;8(2):77. doi: 10.3390/reports8020077.
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive disorder caused by mutations in the gene, leading to impaired bile acid synthesis and systemic cholesterol deposition. The condition presents with a broad spectrum of symptoms affecting multiple organs and systems, including the eyes, central nervous system, tendons, and skeletal muscles. Due to its heterogeneous and often ambiguous clinical manifestations, CTX is frequently misdiagnosed or remains undiagnosed for years. : We report the case of a 37-year-old male who was admitted to our university hospital with a long-standing history of progressive muscle weakness in the arms and legs. His medical history revealed bilateral cataract surgery in childhood, cognitive decline, epilepsy, and bilateral round swellings of the Achilles tendons, suspected to be xanthomas. A clinical diagnosis of CTX was established, and sequencing analysis confirmed the presence of a homozygous pathogenic variant in the gene. Despite the unavailability of chenodeoxycholic acid (CDCA) therapy in Bulgaria, symptomatic management was provided. : This case underscores the diagnostic challenges associated with CTX and highlights the prolonged diagnostic journey faced by patients with rare neurogenetic disorders. It also emphasizes the need for increased awareness and early recognition of such conditions to improve patient outcomes.
脑腱黄瘤病(CTX)是一种罕见的常染色体隐性疾病,由基因突变引起,导致胆汁酸合成受损和全身性胆固醇沉积。该病表现出广泛的症状,影响多个器官和系统,包括眼睛、中枢神经系统、肌腱和骨骼肌。由于其临床表现具有异质性且常常不明确,CTX经常被误诊或多年未被诊断出来。我们报告一例37岁男性患者,因长期存在的手臂和腿部进行性肌肉无力病史入住我们的大学医院。他的病史显示童年时接受过双侧白内障手术、认知能力下降、癫痫以及跟腱双侧圆形肿胀,怀疑是黄瘤。建立了CTX的临床诊断,测序分析证实该基因存在纯合致病变异。尽管保加利亚无法获得鹅去氧胆酸(CDCA)治疗,但仍提供了对症治疗。该病例强调了与CTX相关的诊断挑战,并突出了罕见神经遗传性疾病患者面临的漫长诊断过程。它还强调需要提高对此类疾病的认识并尽早识别,以改善患者预后。